169 related articles for article (PubMed ID: 9552411)
1. p21: structure and functions associated with cyclin-CDK binding.
Ball KL
Prog Cell Cycle Res; 1997; 3():125-34. PubMed ID: 9552411
[TBL] [Abstract][Full Text] [Related]
2. p21 is a component of active cell cycle kinases.
Zhang H; Hannon GJ; Casso D; Beach D
Cold Spring Harb Symp Quant Biol; 1994; 59():21-9. PubMed ID: 7587072
[No Abstract] [Full Text] [Related]
3. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
4. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
Boulaire J; Fotedar A; Fotedar R
Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
[TBL] [Abstract][Full Text] [Related]
5. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
Nakanishi M; Kagawa Y; Takahashi H; Matsushime H
Leukemia; 1997 Apr; 11 Suppl 3():356-7. PubMed ID: 9209388
[TBL] [Abstract][Full Text] [Related]
6. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases.
De Luca A; Santra M; Baldi A; Giordano A; Iozzo RV
J Biol Chem; 1996 Aug; 271(31):18961-5. PubMed ID: 8702560
[TBL] [Abstract][Full Text] [Related]
7. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Wu H; Wade M; Krall L; Grisham J; Xiong Y; Van Dyke T
Genes Dev; 1996 Feb; 10(3):245-60. PubMed ID: 8595876
[TBL] [Abstract][Full Text] [Related]
8. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
Pavletich NP
J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21.
Wang Y; Fisher JC; Mathew R; Ou L; Otieno S; Sublet J; Xiao L; Chen J; Roussel MF; Kriwacki RW
Nat Chem Biol; 2011 Apr; 7(4):214-21. PubMed ID: 21358637
[TBL] [Abstract][Full Text] [Related]
11. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
12. p21/p53, cellular growth control and genomic integrity.
el-Deiry WS
Curr Top Microbiol Immunol; 1998; 227():121-37. PubMed ID: 9479828
[No Abstract] [Full Text] [Related]
13. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
Chellappan SP; Giordano A; Fisher PB
Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
[No Abstract] [Full Text] [Related]
14. Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.
Sung YH; Shin J; Shin J; Lee W
J Biomol Struct Dyn; 2001 Dec; 19(3):419-27. PubMed ID: 11790141
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
Schulze-Gahmen U; Jung JU; Kim SH
Structure; 1999 Mar; 7(3):245-54. PubMed ID: 10368294
[TBL] [Abstract][Full Text] [Related]
17. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Chen WJ; Chang CY; Lin JK
Biochem Pharmacol; 2003 Jun; 65(11):1777-85. PubMed ID: 12781329
[TBL] [Abstract][Full Text] [Related]
18. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
19. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.
Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG
Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
Grzelakowska-Sztabert B
Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
[No Abstract] [Full Text] [Related]
[Next] [New Search]